Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain-Barré Syndrome.
Willem Jan R FokkinkSander J van TilburgBrenda C M de WinterSebastiaan D T SassenPieter A van DoornBirgit C P KochBart C JacobsPublished in: Clinical pharmacokinetics (2022)
This is the first population-pharmacokinetic model for standard IVIg treatment in Guillain-Barré syndrome. The model provides a new tool to predict the pharmacokinetics of alternative regimens of IVIg in Guillain-Barré syndrome to design future trials and personalise treatment.